Table 2.
Open in new tab

Thirty-Day Primary Outcome

Zinc (n = 231)Placebo (n = 239)POR [95% CI]
Death, n (%)15 (6.5)22 (9.2).27.68 [.34–1.35]
ICU admission, n (%)12 (5.2)27 (11.3).01.43 [.21–.87]
Composite outcome, n (%)24 (10.4)40 (16.7).04.58 [.33–.99]
Zinc (n = 231)Placebo (n = 239)POR [95% CI]
Death, n (%)15 (6.5)22 (9.2).27.68 [.34–1.35]
ICU admission, n (%)12 (5.2)27 (11.3).01.43 [.21–.87]
Composite outcome, n (%)24 (10.4)40 (16.7).04.58 [.33–.99]

Abbreviations: CI, confidence interval; ICU, intensive care unit; OR, odds ratio.

Table 2.
Open in new tab

Thirty-Day Primary Outcome

Zinc (n = 231)Placebo (n = 239)POR [95% CI]
Death, n (%)15 (6.5)22 (9.2).27.68 [.34–1.35]
ICU admission, n (%)12 (5.2)27 (11.3).01.43 [.21–.87]
Composite outcome, n (%)24 (10.4)40 (16.7).04.58 [.33–.99]
Zinc (n = 231)Placebo (n = 239)POR [95% CI]
Death, n (%)15 (6.5)22 (9.2).27.68 [.34–1.35]
ICU admission, n (%)12 (5.2)27 (11.3).01.43 [.21–.87]
Composite outcome, n (%)24 (10.4)40 (16.7).04.58 [.33–.99]

Abbreviations: CI, confidence interval; ICU, intensive care unit; OR, odds ratio.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close